Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000899243-23-006004

President and CEO acquired 109,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
AHMED NADIM President and CEO 2023-02-22 Grant or award +109,000 118,710 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
AHMED NADIM President and CEO 2023-02-22 Grant or award · Stock Option (Right to Buy) +211,000 211,000 D: show line 2 in the form
Loading xslF345X03/doc4.xml…